Zeo Scientifix (ZEOX) investor George Shapiro reports 15.1% ownership stake
Rhea-AI Filing Summary
George Shapiro, M.D. filed Amendment No. 1 to a Schedule 13G reporting his beneficial ownership in Zeo Scientifix, Inc. common stock. He reports beneficially owning 1,311,271 shares of common stock, representing 15.1% of the class. These percentages are based on 7,837,441 shares outstanding as of June 12, 2026, as reported by the company. Shapiro has sole voting and sole dispositive power over all 1,311,271 shares, with no shared voting or dispositive power.
Positive
- None.
Negative
- None.
Key Figures
Beneficial ownership: 1,311,271 shares
Percent of class: 15.1%
Shares outstanding baseline: 7,837,441 shares
+2 more
5 metrics
Beneficial ownership
1,311,271 shares
Common Stock beneficially owned by George Shapiro, M.D.
Percent of class
15.1%
Portion of Zeo Scientifix common stock class owned by George Shapiro, M.D.
Shares outstanding baseline
7,837,441 shares
Shares outstanding as of June 12, 2026 used for ownership calculation
Sole voting power
1,311,271 shares
Shares over which Shapiro has sole power to vote or direct the vote
Sole dispositive power
1,311,271 shares
Shares over which Shapiro has sole power to dispose or direct disposition
Key Terms
beneficially owned, Percent of class, Sole Voting Power, Sole Dispositive Power, +1 more
5 terms
beneficially owned financial
"Amount beneficially owned: 1,311,271.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Percent of class financial
"Percent of class: 15.1%"
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.
Sole Voting Power financial
"Sole Voting Power 1,311,271.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Sole Dispositive Power financial
"Sole Dispositive Power 1,311,271.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Schedule 13G regulatory
"Amendment No. 1 to a Schedule 13G reporting"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What ownership in ZEOX does George Shapiro report in this Schedule 13G/A?
George Shapiro, M.D. reports beneficial ownership of 1,311,271 shares of Zeo Scientifix, Inc. common stock, representing 15.1% of the outstanding class, with sole voting and sole dispositive power over all reported shares.
What is the class of securities covered by this Zeo Scientifix (ZEOX) Schedule 13G/A?
The Schedule 13G/A covers Common Stock, par value $0.001, of Zeo Scientifix, Inc., identified by CUSIP 68621D206, held and reported as beneficially owned by George Shapiro, M.D.